Latest Period
Q4 2025
Security Snapshot
Erasca, Inc. - COMMON STOCK (ERAS) Institutional Ownership
CUSIP: 29479A108
13F Institutional Holders and Ownership History from Q3 2021 to Q1 2026
Institutions Reporting
152
Shares (Excl. Options)
219,275,540
Price
$3.72
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / COMMON STOCK
- Symbol
- ERAS on Nasdaq
- Shares outstanding
- 282,656,386
- Price per share
- $17.36
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 219,275,540
- Total reported value
- $815,700,968
- % of total 13F portfolios
- 0%
- Share change
- +455,957
- Value change
- +$5,117,543
- Number of holders
- 152
- Price from insider filings
- $17.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ERAS - Erasca, Inc. - COMMON STOCK is tracked under CUSIP 29479A108.
- 152 institutions reported positions in Q4 2025.
- 6 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 152 to 65 between Q4 2025 and Q1 2026.
- Reported value moved from $815,700,968 to $349,999,022.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 152 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 29479A108?
CUSIP 29479A108 identifies ERAS - Erasca, Inc. - COMMON STOCK in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29479A108:
Significant Owners of Erasca, Inc. - COMMON STOCK (ERAS) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.7% | -21% | $108,913,159 | -$28,532,250 | 16,111,414 | -21% | T. Rowe Price Investment Management, Inc. | 31 Dec 2025 |
| Paradigm Biocapital Advisors LP | 5.3% | $56,391,833 | 15,159,095 | Paradigm BioCapital Advisors LP | 07 Jan 2026 | |||
| Frazier Life Sciences Public Fund, L.P. | 5.3% | -34% | $21,355,029 | -$10,702,679 | 15,038,753 | -33% | Frazier Life Sciences Public Fund, L.P. | 30 Jun 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5.1% | +18% | $20,592,846 | +$3,105,540 | 14,502,004 | +18% | Suvretta Capital Management, LLC | 30 Jun 2025 |
| Logos Global Management LP | 4.8% | -10% | $29,648,000 | -$3,270,000 | 13,600,000 | -9.9% | Logos Global Management LP | 30 Sep 2025 |
| NOVARTIS PHARMA AG | 4.4% | $17,107,692 | 12,307,692 | Novartis Pharma AG | 31 Dec 2024 |
As of 31 Dec 2025, 152 institutional investors reported holding 219,275,540 shares of Erasca, Inc. - COMMON STOCK (ERAS). This represents 78% of the company’s total 282,656,386 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Erasca, Inc. - COMMON STOCK (ERAS) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8% | 22,729,436 | 0% | 2.3% | $84,553,502 |
| VR ADVISER, LLC | 6.3% | 17,857,083 | 0% | 3.3% | $66,428,349 |
| T. Rowe Price Investment Management, Inc. | 5.7% | 16,111,414 | -20% | 0.04% | $59,935,000 |
| BlackRock, Inc. | 5.5% | 15,597,330 | +3.5% | 0% | $58,022,066 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5.1% | 14,502,004 | 0% | 1.3% | $53,947,455 |
| Paradigm Biocapital Advisors LP | 5% | 14,159,095 | +4.4% | 1.4% | $52,671,833 |
| Logos Global Management LP | 4.6% | 13,000,000 | -14% | 3.2% | $48,360,000 |
| VANGUARD GROUP INC | 4.5% | 12,812,156 | +0% | 0% | $47,661,220 |
| ARCH Venture Management, LLC | 3.9% | 11,055,554 | 0% | 6.3% | $41,126,661 |
| Vivo Capital, LLC | 3.3% | 9,273,428 | 0% | 2.2% | $34,497,152 |
| Siren, L.L.C. | 3.1% | 8,757,249 | 0% | 0.97% | $32,576,966 |
| STATE STREET CORP | 2.2% | 6,174,642 | +53% | 0% | $22,969,668 |
| 5AM Venture Management, LLC | 1.9% | 5,405,404 | 0% | 6.3% | $20,108,103 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 4,926,335 | +1.6% | 0% | $18,330,444 |
| Affinity Asset Advisors, LLC | 1.4% | 3,900,000 | -9% | 1% | $14,508,000 |
| Spruce Street Capital LP | 1.4% | 3,889,632 | 0% | 4.8% | $14,469,431 |
| GOLDMAN SACHS GROUP INC | 1.2% | 3,331,418 | +32% | 0% | $12,392,875 |
| a16z Capital Management, L.L.C. | 1% | 2,862,500 | 0% | 0.67% | $10,648,500 |
| MILLENNIUM MANAGEMENT LLC | 0.79% | 2,237,951 | -23% | 0.01% | $8,325,178 |
| Soleus Capital Management, L.P. | 0.76% | 2,162,162 | 0% | 0.34% | $8,043,243 |
| Woodline Partners LP | 0.68% | 1,930,642 | +26% | 0.03% | $7,181,988 |
| DIMENSIONAL FUND ADVISORS LP | 0.63% | 1,775,685 | +29% | 0% | $6,602,155 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.59% | 1,673,404 | -3% | 0% | $6,225,063 |
| BANK OF AMERICA CORP /DE/ | 0.57% | 1,611,850 | +5.1% | 0% | $5,996,083 |
| ExodusPoint Capital Management, LP | 0.53% | 1,490,967 | 0.06% | $5,546,397 |
Institutional Holders of Erasca, Inc. - COMMON STOCK (ERAS) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 21,645,105 | $349,999,022 | +$51,593,402 | $16.18 | 65 |
| 2025 Q4 | 219,275,540 | $815,700,968 | +$5,117,543 | $3.72 | 152 |
| 2025 Q3 | 214,909,404 | $468,512,239 | -$3,508,720 | $2.18 | 138 |
| 2025 Q2 | 218,177,770 | $277,145,224 | -$8,196,772 | $1.27 | 141 |
| 2025 Q1 | 224,275,876 | $307,274,963 | -$9,730,312 | $1.37 | 151 |
| 2024 Q4 | 230,866,824 | $579,481,287 | -$3,886,798 | $2.51 | 144 |
| 2024 Q3 | 232,039,374 | $633,439,326 | +$46,910,487 | $2.73 | 130 |
| 2024 Q2 | 203,567,396 | $480,459,612 | +$311,839,926 | $2.36 | 124 |
| 2024 Q1 | 72,681,232 | $149,721,765 | +$6,866,672 | $2.06 | 105 |
| 2023 Q4 | 69,247,665 | $147,523,921 | -$3,989,593 | $2.13 | 115 |
| 2023 Q3 | 71,279,487 | $140,403,646 | -$6,391,863 | $1.97 | 106 |
| 2023 Q2 | 74,333,071 | $205,158,369 | -$10,901,012 | $2.76 | 110 |
| 2023 Q1 | 78,047,305 | $234,907,735 | -$11,497,274 | $3.01 | 115 |
| 2022 Q4 | 79,824,946 | $344,037,900 | +$2,800,974 | $4.31 | 106 |
| 2022 Q3 | 80,523,466 | $628,084,382 | +$33,781,376 | $7.80 | 87 |
| 2022 Q2 | 76,887,302 | $428,260,749 | +$21,982,237 | $5.57 | 87 |
| 2022 Q1 | 72,825,959 | $626,627,487 | +$45,427,981 | $8.60 | 80 |
| 2021 Q4 | 63,677,801 | $987,988,866 | +$64,674,674 | $15.58 | 63 |
| 2021 Q3 | 44,137,190 | $918,521,616 | +$918,521,616 | $21.22 | 53 |